Takeda Pharmaceutical Company Limited
4502
株式のランク
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
株価
$40.45
時価総額
$64.36B
変化（1日）
1.19%
変化（1年）
43.11%
国
JP
取引 Takeda Pharmaceutical Company Limited (4502)
カテゴリー
Healthcare
Takeda Pharmaceutical Company Limited（4502）の株式分割履歴
Takeda Pharmaceutical Company Limited株（シンボル：4502）は合計で0回の株式分割を実施しました。
最新の株式分割はOct 22, 2026に行われました。
Oct 22, 2026より前に購入された4502株は、現在04502株に相当します。
最新の株式分割はOct 22, 2026に行われました。
Oct 22, 2026より前に購入された4502株は、現在04502株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 提供された日付のデータは十分ではありません。 | |||
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
|
| 0 | - |
CN
|
